Financial Highlights (Quarterly Data)
Explanation of consolidated financial results
2Q of FY2023 (Announced on November 6, 2023)
- Sales increased due to the positive effects of price increases and foreign exchange rate changes. The food business contributed to profits, resulting in 22% more operating profit than the previous year's. In total, the plan has progressed smoothly.
- Quarterly profit attributable to owners of parent remains the same as the previous year, partly due to a gain on the sale of shares of Nissui Pharmaceutical (*) in the last year.
- The interim dividend will be 10 yen, an increase of 2 yen.
(*)now Shimadzu Diagnostics Corporation